A loss‐of‐function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa
Experimental Dermatology · 2023
DOI: 10.1111/exd.14919 ↗At a glance
Journal article in Experimental Dermatology, 2023. Written by Ana Sofia Lima Estevao de Oliveira and 11 co-authors. Institution: Keizo Asami Institute-iLIKA, Federal University of Pernambuco, Recife, Brazil. Major MEDLINE topics: Hidradenitis Suppurativa, Malignant Atrophic Papulosis. Cited 6 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Dowling Degos disease (DDD) is a rare autosomal dominant genodermatosis characterized by acquired, slowly progressive reticulated pigmented lesions primarily involving flexural skin areas. Mutations in KRT5 , POGLUT ‐ 1 and POFUT ‐ 1 genes have been associated with DDD, and loss‐of‐function mutations in PSENEN , a subunit of the gamma‐secretase complex, were found in patients presenting with DDD or DDD comorbid with hidradenitis suppurativa (HS). A nonsense mutation in NCSTN , another subunit of the gamma‐secretase, was already described in a patient suffering from HS and DDD but whether NCSTN could be considered a novel gene for DDD is still debated. Here, we enrolled a four‐generation family with HS and DDD. Through Whole Exome Sequencing (WES) we identified a novel nonsense mutation in the NCSTN gene in all the affected family members. To study the impact of this variant, we isolated outer root sheath cells from patients' hair follicles. We showed that this variant leads to a premature stop codon, activates a nonsense‐mediated mRNA decay, and causes NCSTN haploinsufficiency in affected individuals. In fact, cells treated with gentamicin, a readthrough agent, had the NCSTN levels corrected. Moreover, we observed that this haploinsufficiency also affects other subunits of the gamma‐secretase complex, possibly causing DDD. Our findings clearly support NCSTN as a novel DDD gene and suggest carefully investigating this co‐occurrence in HS patients carrying a mutation in the NCSTN gene.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Keizo Asami Institute-iLIKA, Federal University of Pernambuco, Recife, Brazil.
- Hospital das Clínicas, Federal University of Pernambuco, Recife, Brazil.
- Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, Créteil, France.
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", Department of Advanced Diagnostics, Trieste, Italy.
- Laboratory of Nanostructured Materials (LMNANO), Center for Strategic Technologies Northeastern (CETENE), Recife, Brazil.
- University of Trieste, Department of Medical Surgical and Health Sciences, Trieste, Italy.
ORCID profiles: Ana Sofia Lima Estevao de Oliveira, Michele Boniotto
Cite
APA
de Oliveira, A. S. L. E., de Siqueira, R. C., Nait-Meddour, C., Tricarico, P. M., Moura, R., Agrelli, A., d'Adamo, A. P., Jamain, S., Crovella, S., de Fátima Medeiros Brito, M., Boniotto, M., & Brandão, L. A. C. (2023). A loss‐of‐function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa. Experimental Dermatology. https://doi.org/10.1111/exd.14919
Vancouver
de Oliveira ASLE, de Siqueira RC, Nait-Meddour C, Tricarico PM, Moura R, Agrelli A, et al. A loss‐of‐function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa. Experimental Dermatology. 2023. doi:10.1111/exd.14919
BibTeX
@article{deOliveira2023,
author = {de Oliveira, Ana Sofia Lima Estevao and de Siqueira, Roberta Cardoso and Nait-Meddour, Cécile and Tricarico, Paola Maura and Moura, Ronald and Agrelli, Almerinda and d'Adamo, Adamo Pio and Jamain, Stéphane and Crovella, Sergio and de Fátima Medeiros Brito, Maria and Boniotto, Michele and Brandão, Lucas André Cavalcanti},
title = {A loss‐of‐function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa},
journal = {Experimental Dermatology},
year = {2023},
doi = {10.1111/exd.14919}
}
EUVIMED